Correspondence | Published:

Outcome of αβ T cell-depleted transplantation in children with high-risk acute myeloid leukemia, grafted in remission

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Chaleff S, Otto M, Barfield RC, Leimig T, Iyengar R, Martin J, et al. A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy. 2007;9:746–54. https://doi.org/10.1080/14653240701644000.

  2. 2.

    Handgretinger R. New approaches to graft engineering for haploidentical bone marrow transplantation. Semin Oncol. 2012;39:664–73. https://doi.org/10.1053/j.seminoncol.2012.09.007.

  3. 3.

    Schumm M, Lang P, Bethge W, Faul C, Feuchtinger T, Pfeiffer M, et al. Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy. 2013;15:1253–8. https://doi.org/10.1016/j.jcyt.2013.05.014.

  4. 4.

    Maschan M, Shelikhova L, Ilushina M, Kurnikova E, Boyakova E, Balashov D, et al. TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia. Bone Marrow Transpl. 2016;51:668–74. https://doi.org/10.1038/bmt.2015.343.

  5. 5.

    Balashov D, Shcherbina A, Maschan M, Trakhtman P, Skvortsova Y, Shelikhova L, et al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCRalphabeta and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transpl. 2015;21:1955–62. https://doi.org/10.1016/j.bbmt.2015.07.008.

  6. 6.

    Bertaina A, Merli P, Rutella S, Pagliara D, Bernardo ME, Masetti R, et al. HLA-haploidentical stem cell transplantation after removal of alphabeta+T and B cells in children with nonmalignant disorders. Blood. 2014;124:822–6. https://doi.org/10.1182/blood-2014-03-563817.

  7. 7.

    Locatelli F, Merli P, Pagliara D, Li Pira G, Falco M, Pende D, et al. Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion. Blood. 2017;130:677–85. https://doi.org/10.1182/blood-2017-04-779769.

  8. 8.

    Bertaina A, Zecca M, Buldini B, Sacchi N, Algeri M, Saglio F, et al. Unrelated donor vs HLA-haploidentical alpha/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood. 2018;132:2594–607. https://doi.org/10.1182/blood-2018-07-861575.

  9. 9.

    Maschan M, Blagov S, Shelikhova L, Shekhovtsova Z, Balashov D, Starichkova J, et al. Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial. Bone Marrow Transpl. 2018;53:264–73. https://doi.org/10.1038/s41409-017-0035-y.

  10. 10.

    Shelikhova L, Ilushina M, Shekhovtsova Z, Shasheleva D, Khismatullina R, Kurnikova E, et al. Alphabeta T cell-depleted haploidentical hematopoietic stem cell transplantation without antithymocyte globulin in children with chemorefractory acute myelogenous leukemia. Biol Blood Marrow Transplant 2019. https://doi.org/10.1016/j.bbmt.2019.01.023

  11. 11.

    MacMillan ML, Davies SM, Nelson GO, Chitphakdithai P, Confer DL, King RJ, et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transpl. 2008;14:16–22. https://doi.org/10.1016/j.bbmt.2008.05.019.

  12. 12.

    Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 2011;118:1402–12. https://doi.org/10.1182/blood-2010-08-304121.

  13. 13.

    Handgretinger R, Schilbach K. The potential role of gammadelta T cells after allogeneic HCT for leukemia. Blood. 2018;131:1063–72. https://doi.org/10.1182/blood-2017-08-752162.

  14. 14.

    Handgretinger R, Lang P, Andre MC. Exploitation of natural killer cells for the treatment of acute leukemia. Blood. 2016;127:3341–9. https://doi.org/10.1182/blood-2015-12-629055.

  15. 15.

    Leung W. Use of NK cell activity in cure by transplant. Br J Haematol. 2011;155:14–29. https://doi.org/10.1111/j.1365-2141.2011.08823.x.

  16. 16.

    Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–100. https://doi.org/10.1126/science.1068440.

Download references

Acknowledgements

The authors thank the physicians and nursing staff of the Hematopoietic stem cell transplantation Units 1 and 2 for outstanding patient care, the staff of molecular biology, cytogenetics, microbiology and transplant biology laboratories for excellent service, Marina Persiantseva and Susanne Morsch for unrelated donor search. We are grateful to the “Podari Zhizn” foundation for continued support of the care of the patients and research in the field of hematopoietic stem cell transplantation.

Author information

Correspondence to Michael Maschan.

Ethics declarations

Conflict of interest

MM received lecturer’s fee from Miltenyi Biotec GmbH. The remaining authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary tables and figures

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1